Reinilde Heyrman
Directeur Technique/Scientifique/R&D chez MEDPACE HOLDINGS, INC.
Postes actifs de Reinilde Heyrman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MEDPACE HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2017 | - |
Historique de carrière de Reinilde Heyrman
Anciens postes connus de Reinilde Heyrman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | 01/01/2012 | - |
| BELLEROPHON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2014 | - |
| Secrétaire Général | 01/02/2014 | - |
Formation de Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Belgique | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Bourse
- Insiders
- Reinilde Heyrman
- Expérience
